成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Hormones and the Endocrine System>Contraceptives>Levonorgestrel
Levonorgestrel
  • Levonorgestrel

Levonorgestrel NEW

Price $42
Package 100mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-05

Product Details

Product Name: Levonorgestrel CAS No.: 797-63-7
Purity: 99.83% Supply Ability: 10g
Release date: 2024/11/05

Product Introduction

Bioactivity

名稱Levonorgestrel
描述Levonorgestrel (D-Norgestrel) is a Progestin and Progestin-containing Intrauterine Device. The physiologic effect of levonorgestrel is by means of Inhibit Ovum Fertilization.
體外活性Levonorgestrel significantly upregulates mRNA expression of the gene encoding luteinizing hormone beta subunit (lhβ) in both male and female cockroaches, while downregulating mRNA expression of the gene encoding follicle-stimulating hormone beta subunit (fshβ). Furthermore, in long-clawed ground squirrels, Levonorgestrel decreases the mRNA expression of ovarian follicle-stimulating hormone receptor, luteinizing hormone receptor, ovarian estrogen receptor β, and progesterone receptor, as well as the mRNA expression of ERα and PR in the uterus.
體內(nèi)活性Levonorgestrel elevates cyclic AMP levels in the veins and inhibits the activation of protein kinase C induced by PMA. It suppresses progesterone secretion in rat luteal cells, which is stimulated by oLH, dibutyryl-cAMP, and pregnenolone. Levonorgestrel also inhibits contractions induced by high potassium (K(+)) solutions or PMA in the presence and absence of extracellular calcium (Ca(2+)), effectuating endothelium-dependent relaxation through hindrance of calcium ion ingress and protein kinase C activation. Moreover, while the inhibitory effects of Levonorgestrel on estrogen-induced pituitary weight gain and hyperprolactinemia are attenuated by mifepristone, flunarizine does not block its effects.
存儲條件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 16.67 mg/mL (53.34 mM)
關(guān)鍵字Levonorgestrel | NR3C3 | Progesterone Receptor | Inhibitor | inhibit
相關(guān)產(chǎn)品Kaempferol | Tamoxifen | Mifepristone | Estradiol | Astragaloside IV | Estradiol benzoate | Melatonin | Allura Red AC | Ethisterone
相關(guān)庫經(jīng)典已知活性庫 | 兒童藥物庫 | 肝臟毒性化合物庫 | 藥物功能重定位化合物庫 | 抑制劑庫 | NO PAINS 化合物庫 | FDA 上市藥物庫 | 口服活性化合物庫 | 臨床期小分子藥物庫 | 已知活性化合物庫

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$42.00/100mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-05
$0.00/25KG
VIP5Y
Hebei Mojin Biotechnology Co., Ltd
2024-10-11
$0.00/1kg
VIP1Y
Wuhan Fortuna Chemical Co.,Ltd
2024-08-01
$0.00/1KG
VIP2Y
Wuhan Haorong Biotechnology Co.,Ltd
2023-07-27
$18.00/1kg
Wuhan Boyuan Import & Export Co., LTD
2023-07-06
$0.00/1KG
Hubei Harvest Chemical CO.,Ltd
2022-12-27
$0.00/1kg
VIP3Y
Wuhan Senwayer Century Chemical Co.,Ltd
2022-12-06
$9.90/10g
Shanghai Biolang Biotechnology Co., Ltd.
2022-02-23
$1.00/1kg
Wuhan Dujiang Industrial Co., Ltd.
2022-02-22
$1.50/1KG
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
2022-01-07
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY